SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+1.53%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$427M
AUM Growth
+$427M
(+1.1%)
Cap. Flow
-$3.29M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
56.98%
Holding
37
New
6
Increased
10
Reduced
14
Closed
4
Top Buys
| 1 |
Stryker
SYK
|
$17M |
| 2 |
Bristol-Myers Squibb
BMY
|
$10.6M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$8.36M |
| 5 |
Community Health Systems
CYH
|
$6.08M |
Top Sells
| 1 |
AbbVie
ABBV
|
$12.9M |
| 2 |
Agilent Technologies
A
|
$9.6M |
| 3 |
Eli Lilly
LLY
|
$9.47M |
| 4 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$6.71M |
| 5 |
Edwards Lifesciences
EW
|
$6.44M |
Sector Composition
| 1 | Healthcare | 85.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $49.9M | 11.68% | 770,147 -146,000 | -16% | -$9.47M |
|
2
Baxter International
BAX
$12.7B
| $36.7M | 8.59% | 511,800 -30,000 | -6% | -$2.15M |
|
3
Boston Scientific
BSX
$156B
| $30.1M | 7.04% | 2,547,600 +30,000 | +1% | +$354K |
|
|
4
Edwards Lifesciences
EW
$47.8B
| $24.2M | 5.67% | 237,300 -63,000 | -21% | -$6.44M |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $18.3M | 4.28% | 340,600 +6,000 | +2% | +$322K |
|
6
Revvity
RVTY
$10.5B
| $17.3M | 4.05% | 397,460 +2,000 | +0.5% | +$87.2K |
|
|
7
Stryker
SYK
$150B
| $17M | 3.97% | +210,183 | New | +$17M |
|
8
Quest Diagnostics
DGX
$20.3B
| $16.9M | 3.96% | 279,128 -4,000 | -1% | -$243K |
|
|
THOR
9
DELISTED
THORATEC CORPORATION
THOR
| $16.8M | 3.93% | 628,300 +70,000 | +13% | +$1.87M |
|
|
10
Bristol-Myers Squibb
BMY
$96B
| $16.2M | 3.8% | 317,000 +207,000 | +188% | +$10.6M |
|
11
Cardinal Health
CAH
$35.5B
| $15M | 3.51% | 200,000 -7,000 | -3% | -$524K |
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $14.7M | 3.45% | 1,138,291 -20,200 | -2% | -$262K |
|
|
LPNT
13
DELISTED
LifePoint Health, Inc.
LPNT
| $13.8M | 3.23% | 199,700 | – | – |
|
14
Tenet Healthcare
THC
$16.3B
| $13.6M | 3.19% | 229,500 -48,700 | -18% | -$2.89M |
|
|
CBST
15
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $13.3M | 3.1% | 199,990 +7,500 | +4% | +$498K |
|
16
ResMed
RMD
$40.2B
| $11.4M | 2.67% | 231,300 -18,000 | -7% | -$887K |
|
|
PDCO
17
DELISTED
Patterson Companies, Inc.
PDCO
| $10.7M | 2.51% | 258,465 | – | – |
|
|
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
| $10.4M | 2.44% | +173,145 | New | +$10.4M |
|
|
HSP
19
DELISTED
HOSPIRA INC
HSP
| $10.4M | 2.43% | 200,000 -33,800 | -14% | -$1.76M |
|
20
Bio-Rad Laboratories Class A
BIO
$8.06B
| $8.74M | 2.05% | 77,100 +10,800 | +16% | +$1.22M |
|
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $8.36M | 1.96% | +74,463 | New | +$8.36M |
|
22
Cencora
COR
$56.5B
| $7.58M | 1.77% | 98,000 -2,000 | -2% | -$155K |
|
|
23
Community Health Systems
CYH
$387M
| $6.08M | 1.42% | +111,000 | New | +$6.08M |
|
|
ACOR
24
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $5.98M | 1.4% | 176,600 -198,000 | -53% | -$6.71M |
|
|
VOLC
25
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $5.93M | 1.39% | +557,000 | New | +$5.93M |
|